| Literature DB >> 28523731 |
Hyun Ji Cho1, Young Sang Kwon2, Da-Ran Kim3, Gyeongjun Cho1, Seong Won Hong1, Dong-Won Bae4, Youn-Sig Kwak1.
Abstract
Streptomyces griseus S4-7 was originally isolated from the strawberry rhizosphere as a microbial agent responsible for Fusarium wilt suppressive soils. S. griseus S4-7 shows specific and pronounced antifungal activity against Fusarium oxysporum f. sp. fragariae. In the Streptomyces genus, the whi transcription factors are regulators of sporulation, cell differentiation, septation, and secondary metabolites production. wblE2 function as a regulator has emerged as a new group in whi transcription factors. In this study, we reveal the involvement of the wblE2 transcription factor in the plant-protection by S. griseus S4-7. We generated ΔwblE, ΔwblE2, ΔwhiH, and ΔwhmD gene knock-out mutants, which showed less antifungal activity both in vitro and in planta. Among the mutants, wblE2 mutant failed to protect the strawberry against the Fusarium wilt pathogen. Transcriptome analyses revealed major differences in the regulation of phenylalanine metabolism, polyketide and siderophore biosynthesis between the S4-7 and the wblE2 mutant. The results contribute to our understanding of the role of streptomycetes wblE2 genes in a natural disease suppressing system.Entities:
Keywords: antibiotic production; biological control; streptomycetes; wblE2 transcription factors
Mesh:
Substances:
Year: 2017 PMID: 28523731 PMCID: PMC5635160 DOI: 10.1002/mbo3.494
Source DB: PubMed Journal: Microbiologyopen ISSN: 2045-8827 Impact factor: 3.139
List of strains and plasmids used in this study
| Strains/plasmids | Description | Reference |
|---|---|---|
|
| ||
| DH5α |
| Kieser et al. ( |
| ET12567/pUZ8002 |
| Kieser et al. ( |
|
| ||
| S4‐7 | Wild‐type | Cha et al. ( |
| Δ | S4‐7Δ | This work |
| Δ | S4‐7Δ | This work |
| Δ | S4‐7Δ | This work |
| Δ | S4‐7Δ | This work |
| S4‐7 | S4‐7 | This work |
| Plasmid | ||
| pKC1132 |
| Bierman et al. ( |
| pIJ10257 | Mobilizable vector, integrates at ΦC31 | Novotna et al. ( |
| pKC46 | pKC1132 containing | This work |
| pKC14 | pKC1132 containing | This work |
| pKC54 | pKC1132 containing | This work |
| pKC11 | pKC1132 containing | This work |
| pIJ46 | pIJ10257 containing | This work |
Sporulation phenotype, and antifungal and biocontrol activities of whi mutants
| Strain | Gene function | Sporulation | in vitro antifungal activity |
|
|---|---|---|---|---|
| Δ |
| + | ‐ | ‐ |
| Δ | Transcriptional regulator, | ++ | + | ++ |
| Δ |
| + | ‐ | + |
| Δ |
| + | ‐ | ‐ |
| S4‐7 | Wild‐type | ++++ | ++++ | ++++ |
Figure 1Colony morphology of member of whi transcription factor mutants. Cultures of the mutants were incubated for 7 days on PDK medium at 30°C. (a) wild‐type (S4‐7); (b) ΔwblE; (c) ΔwhiH; (d) ΔwhmD; E, ΔwblE2
Figure 2Antagonism test of whi mutants. The mutants (a, ΔwblE; b, ΔwhiH; c, ΔwhmD; d, ΔwblE2, E: overexpression of wblE2 gene) lost their antagonistic activity against F. oxysporum, as assayed on PDK medium at 28°C for 7 days. The wild‐type, S4‐7, was streaked on the top of each plate
Figure 3Biological control ability of S. griseus S4‐7 and mutants in growth chamber experiments. (a) CK, control; S, S. griseus S4‐7 with 0.1% methylcellulose; F9, F. oxysporum chlamydospores (1.6 × 105 cfu/g of soil), each mutant (4.2 × 107 cfu/ml) was treated with 0.1% methylcellulose. F. oxysporum chlamydospore inoculum was added to the soil samples at a dose of 1.6 × 105 cfu/g of soil, following which the strawberries (50‐d‐old cv. Sulhyang) were planted in each pot. B; Disease incidence and severity were assessed over 45 days after planting. Disease index represents the number of strawberry leaves with symptoms: 0, healthy; 1, 1 to 3 leaves rolled and yellowed; 2, >3 leaves rolled and deformed; 3, chlorosis and early plant wilting; 4, necrosis and entire plant wilting; and 5, dead or nearly dead
Genes identified as differentially regulated by transcriptome comparisons of S. griseus S4‐7 and ΔwblE2 mutant and their biological pathways
| Gene name | KEGG pathway |
|---|---|
| Group A | Not expressed in |
| SGS47207490 | Two‐component system |
| SGS47207500 | Two‐component system |
| SGS47208000 | Selenocompound metabolism; Stilbenoid, diarylheptanoid, and gingerol biosynthesis; Polycyclic aromatic hydrocarbon degradation |
| SGS47208360 | Limonene and pinene degradation; Stilbenoid, diarylheptanoid, and gingerol biosynthesis; Aminobenzoate degradation; Polycyclic aromatic hydrocarbon degradation |
| SGS47208040 | Nucleotide excision repair |
| SGS47208350 | Carotenoid biosynthesis |
| SGS47208060 | Fructose and mannose metabolism; Butanoate metabolism; Linoleic acid metabolism; Chloroalkane and chloroalkene degradation; Bisphenol degradation |
| SGS47208030 | ABC transporters |
| SGS47208230 | Phenylalanine metabolism |
| SGS47208250 | Degradation of aromatic compounds; Tyrosine metabolism |
| SGS47208070 | Fructose and mannose metabolism; Amino sugar and nucleotide sugar metabolism |
| SGS47208140 | Phenylalanine, tyrosine, and tryptophan biosynthesis |
| SGS47208130 | Phenylalanine, tyrosine, and tryptophan biosynthesis |
| SGS47207970 | Phosphotransferase system (PTS) |
| SGS47208170 | Tyrosine metabolism; Limonene and pinene degradation; Benzoate degradation; Aminobenzoate degradation; Ethylbenzene degradation |
| SGS47208210 | Polyketide sugar unit biosynthesis; Biosynthesis of vancomycin group antibiotics; Streptomycin biosynthesis |
| SGS47208110 | Polyketide sugar unit biosynthesis |
| SGS47208090 | Amino sugar and nucleotide sugar metabolism; Two‐component system |
| SGS47188580 | Salivary secretion |
| SGS47208490 | Steroid degradation |
| SGS47208530 | Histidine metabolism; Limonene and pinene degradation; Aminobenzoate degradation; Chlorocyclohexane and chlorobenzene degradation; Toluene degradation; Bisphenol degradation; Naphthalene degradation; Polycyclic aromatic hydrocarbon degradation |
| SGS47208370 | Steroid degradation |
| SGS47209050 | Salmonella infection |
| Group B | Down‐regulated in |
| SGS47149320 | Sulfur metabolism; Purine metabolism; Selenocompound metabolism |
| SGS47207010 | Starch and sucrose metabolism |
| SGS47184540 | Lysine degradation |
| SGS47196940 | ABC transporters |
| SGS47207550 | Glyoxylate and dicarboxylate metabolism; Nitrogen metabolism |
| SGS47207540 | Butanoate metabolism; C5‐Branched dibasic acid metabolism; Valine, leucine, and isoleucine biosynthesis; Pantothenate and CoA biosynthesis |
| SGS47142800 | Complement and coagulation cascades |
| SGS47199650 | Nicotinate and nicotinamide metabolism |
| SGS47199660 | Microbial metabolism in diverse environments |
| SGS47208180 | Polyketide sugar unit biosynthesis; Streptomycin biosynthesis |
| SGS47190590 | FoxO signaling pathway; cGMP‐PKG signaling pathway; AMPK signaling pathway; Insulin signaling pathway; Adipocytokine signaling pathway; Adipocytokine signaling pathway; Type II diabetes mellitus |
| SGS47208430 | Biosynthesis of siderophore group nonribosomal peptides |
| SGS47208400 | Porphyrin and chlorophyll metabolism |
| SGS47145360 | Amino sugar and nucleotide sugar metabolism |
| SGS47208310 | Histidine metabolism |
| SGS47208460 | Arginine and proline metabolism |
| SGS47208320 |
|
| SGS47208120 | Metabolism of xenobiotics by cytochrome P450; Bile secretion; Chemical carcinogenesis |
| SGS47208290 | Biosynthesis of siderophore group nonribosomal peptides |
| Group C | Equally expressed |
| SGS47146480 | Pentose and glucuronate interconversions; Metabolism of xenobiotics by cytochrome P450 |
| Group D | Overexpressed in |
| SGS47190030 | ABC transporters |
| SGS47190040 | ABC transporters |
Figure 4Heatmap of mutant and wild‐type RNA‐seq transcriptomes. The DEG cut‐off was set at Fold‐change >5 and p ≤ .005 in edgeR. Sorted genes were classified with eggNOG and visualized by gplots version 3.0.1 and ggplot2 version 2.1.0 (R package)